These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 20495466

  • 1. Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.
    Kao J, Kwok K, Das KM.
    J Clin Gastroenterol; 2010 Sep; 44(8):531-5. PubMed ID: 20495466
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ.
    Rev Gastroenterol Disord; 2006 Sep; 6(2):97-105. PubMed ID: 16699478
    [Abstract] [Full Text] [Related]

  • 4. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May 18; 51(1312):38-9. PubMed ID: 19448588
    [Abstract] [Full Text] [Related]

  • 5. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
    Hanauer SB.
    Aliment Pharmacol Ther; 2006 Oct 18; 24 Suppl 3():37-40. PubMed ID: 16961743
    [Abstract] [Full Text] [Related]

  • 6. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK, Irvine EJ.
    Am J Gastroenterol; 2000 Jul 18; 95(7):1628-36. PubMed ID: 10925961
    [Abstract] [Full Text] [Related]

  • 7. Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance rates.
    Osterman MT, Lichtenstein GR.
    Methods Find Exp Clin Pharmacol; 2009 Jul 18; 31(1):41-6. PubMed ID: 19357797
    [Abstract] [Full Text] [Related]

  • 8. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
    Jo Y, Matsumoto T, Iida M.
    Nihon Rinsho; 2005 May 18; 63(5):820-4. PubMed ID: 15881176
    [Abstract] [Full Text] [Related]

  • 9. Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.
    Safdi AV, Cohen RD.
    Aliment Pharmacol Ther; 2007 Nov 01; 26(9):1179-86. PubMed ID: 17944732
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS, Riff DS, Pruitt R, Wruble L, Koval G, Sales D, Bell JK, Johnson LK.
    Am J Gastroenterol; 2002 Jun 01; 97(6):1398-407. PubMed ID: 12094857
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L, Cohen H, Dooley C, Rubin P, Orchard J.
    Am J Gastroenterol; 1996 Jul 01; 91(7):1338-42. PubMed ID: 8677990
    [Abstract] [Full Text] [Related]

  • 13. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
    Schroeder KW.
    Scand J Gastroenterol Suppl; 2002 Jul 01; (236):42-7. PubMed ID: 12408503
    [Abstract] [Full Text] [Related]

  • 14. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU, Bokemeyer B, Adamek H, Mross M, Vinter-Jensen L, Börner N, Silvennoinen J, Tan G, Pool MO, Stijnen T, Dietel P, Klugmann T, Vermeire S, Bhatt A, Veerman H.
    Clin Gastroenterol Hepatol; 2009 Jul 01; 7(7):762-9. PubMed ID: 19375519
    [Abstract] [Full Text] [Related]

  • 15. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov 01; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 16. Mesalamine with MMX technology for the treatment of ulcerative colitis.
    Schreiber S, Kamm MA, Lichtenstein GR.
    Expert Rev Gastroenterol Hepatol; 2008 Jun 01; 2(3):299-314. PubMed ID: 19072380
    [Abstract] [Full Text] [Related]

  • 17. Can oral 5-aminosalicylic acid be administered once daily in the treatment of mild-to-moderate ulcerative colitis? A meta-analysis of randomized-controlled trials.
    Zhu Y, Tang RK, Zhao P, Zhu SS, Li YG, Li JB.
    Eur J Gastroenterol Hepatol; 2012 May 01; 24(5):487-94. PubMed ID: 22465970
    [Abstract] [Full Text] [Related]

  • 18. MMX mesalamine.
    Baker DE.
    Rev Gastroenterol Disord; 2006 May 01; 6(3):146-52. PubMed ID: 16957657
    [Abstract] [Full Text] [Related]

  • 19. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD, Woseth DM, Thisted RA, Hanauer SB.
    Am J Gastroenterol; 2000 May 01; 95(5):1263-76. PubMed ID: 10811338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.